Sanofi Files 6-K Report for April 2024

Ticker: SNYNF · Form: 6-K · Filed: Apr 25, 2024 · CIK: 1121404

Sanofi 6-K Filing Summary
FieldDetail
CompanySanofi (SNYNF)
Form Type6-K
Filed DateApr 25, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: 6-K, regulatory-filing, foreign-private-issuer

TL;DR

Sanofi dropped its April 6-K, including a press release. Check it for Q1 updates.

AI Summary

Sanofi filed a Form 6-K on April 25, 2024, reporting on its activities for the month of April 2024. The filing incorporates by reference a press release issued by the company as Exhibit 99.1. This report covers the period ending March 31, 2024.

Why It Matters

This filing provides an update on Sanofi's ongoing operations and disclosures as a foreign private issuer, which is important for investors tracking the company's regulatory compliance and recent activities.

Risk Assessment

Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or strategic information that would inherently increase risk.

Key Players & Entities

  • Sanofi (company) — Registrant
  • 001-31368 (company) — SEC File Number
  • 20240425 (date) — Filing Date
  • 20240331 (date) — Reporting Period End Date

FAQ

What type of report is Sanofi filing?

Sanofi is filing a Form 6-K, which is a Report of Foreign Private Issuer.

What is the commission file number for Sanofi?

Sanofi's commission file number is 001-31368.

What period does this report cover?

This report is for the month of April 2024 and covers the period ending March 31, 2024.

What is incorporated by reference into this filing?

A press release issued by Sanofi in April 2024, attached as Exhibit 99.1, is incorporated by reference.

Where is Sanofi's principal executive office located?

Sanofi's principal executive offices are located at 46, avenue de la Grande Armée, 75017 Paris, France.

Filing Stats: 178 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2024-04-25 10:49:31

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated April 25, 2024 SANOFI By s Alexandra Roger Name Alexandra Roger Title Head of Legal Corporate Finance

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.